Rx only · Injection · Intravenous

Cisplatin

3 ACTIVE SUPPLIERS — US

openFDA · updated weekly

US4 NDCs
3 active makers

UKComing
soon

CAComing
soon

AUComing
soon

EUComing
soon

ATCL01XA01

RxCUI (US)2555

US makers3 labelers

Packages6

DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.2K

Rx · 2026 Q1

92K

Units dispensed

-47%

Rx vs. year ago

Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Labeler	Type	Packages	Status
Hikma Pharmaceuticals USA Inc.	unknown	2	SUPPLYING
Accord Healthcare Inc.	unknown	2	SUPPLYING
BluePoint Laboratories	unknown	2	SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

Oct 1, 2024
RECALLRecall (Class II): Cisplatin Injection, 100mg/100mL (1mg/mL), For Intravenous Use, 100 mL Multiple Dose Vial, Rx Only, Manufactured for: A…
Failed Impurities/Degradation Specifications. — Recalling firm: ACCORD HEALTHCARE, INC. — Nationwide within the United States and PR